Q3 2020 Holdings
Filed 2020-11-13 | 62 holdings | $262.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $71.9M | 3,323,051 | 27.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $45.5M | 3,066,797 | 17.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $44.5M | 169,600 | 16.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $44.5M | 2,597,222 | 16.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $24.1M | 638,928 | 9.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $23.7M | 3,559,722 | 9.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $7.0M | 1,743,712 | 2.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $143.9K | 3,378,380 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $97.9K | 2,053,991 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $94.3K | 3,064,734 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $85.0K | 2,630,658 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $80.2K | 2,068,098 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $78.8K | 4,182,243 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $73.1K | 2,101,049 | 0.0% |
| Merus N V | COM | N5749R100 | $67.7K | 5,645,571 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $47.9K | 9,818,758 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $46.4K | 2,372,288 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $45.6K | 1,489,112 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.2K | 1,198,427 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $40.5K | 3,226,769 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $38.9K | 1,691,834 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $38.7K | 3,499,346 | 0.0% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $37.7K | 777,553 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $37.6K | 8,009,353 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $36.5K | 2,470,678 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $34.9K | 735,055 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $31.0K | 3,087,195 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $23.5K | 2,149,057 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $22.2K | 7,244,262 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $21.0K | 8,459,547 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $20.8K | 3,622,051 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $20.7K | 3,005,589 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $20.4K | 17,426,968 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.1K | 1,227,405 | 0.0% |
| Calliditas Therapeutics AB | SPONSORED ADS | 13124Q106 | $18.0K | 750,000 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $15.8K | 4,585,638 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $15.0K | 1,344,334 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $14.9K | 6,929,690 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $14.4K | 1,000,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $13.0K | 10,747,994 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $12.7K | 4,080,162 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $11.8K | 322,098 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $11.4K | 5,494,582 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $10.7K | 3,766,704 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $9.6K | 800,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $9.2K | 4,012,404 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $8.9K | 2,143,667 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $8.4K | 1,600,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $8.3K | 800,000 | 0.0% |
| Evelo Biosciences Inc | COM | 299734103 | $6.9K | 1,300,000 | 0.0% |